It could stop the spread and recurrence of breast cancer
, 1,836 patients took part. All had previously received chemotherapy treatment for breast cancer, and half the group were then given olaparib, while the other half were given a placebo.
Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere: